Preferences and experiences with colorectal cancer screening methods
Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
This test asks people aged 50–69 who completed a stool (FOBT) screen to share which colorectal cancer screening methods they prefer and how they experienced the screening program.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 50 Years to 69 Years |
| Sex | All |
| Sponsor | Advanced Marker Discovery S.l. Industry-sponsored |
| Locations | 2 sites (Lisbon and 1 other locations) |
| Trial ID | NCT06696534 on ClinicalTrials.gov |
What this trial studies
This low-risk interventional project invites adults aged 50–69 participating in a population-based colorectal screening program to complete two questionnaires about their screening experience and method preferences after undergoing a fecal occult blood test (FOBT). Participants provide informed consent and relevant clinical information from the screening visit is shared with study staff for analysis. Surveys are administered at participating primary care centers in Lisbon and Madrid to capture values, preferences, and reported experiences. Results will be analyzed to identify patterns that could inform how screening options and communications are offered to patients.
Who should consider this trial
Good fit: Ideal candidates are asymptomatic adults aged 50–69 invited to the local population-based screening program who have delivered a stool (FOBT) sample and can give informed consent.
Not a fit: People who have not provided a stool sample, who previously had a colonoscopy because of a positive FOBT, who are outside the 50–69 age range, symptomatic, or in a dependent relationship with the investigators or sponsor are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, the results could help programs offer screening methods and communications that better match patient preferences, potentially increasing participation and satisfaction.
How similar studies have performed: Questionnaire-based studies in colorectal screening programs have previously identified patient preferences that informed program design, so the approach is established though results vary by population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants ages from 50 to 69 years (both included) at the time of informed consent signed. * Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center. * Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form. Exclusion Criteria: * Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form. * Participants with a previous colonoscopy in consequence of a FOBT positive result. * Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.
Where this trial is running
Lisbon and 1 other locations
- UCSP Sete Rios — Lisbon, Portugal (Not_yet_recruiting)
- CS Mar Báltico — Madrid, Madrid, Spain (Recruiting)
Study contacts
- Principal investigator: Maria A Perez, MD — Primary Health Care Centre Mar Báltico
- Study coordinator: Marta Jimenez, PhD
- Email: mjimenez@amadix.com
- Phone: +34 637899149
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.